As far as many patient groups are concerned, the theme song for the pharmaceutical industry should be Joan Jett’s “Bad Reputation.” For all the criticism that drug makers have endured in

recent years, a new survey finds that they are faring worse than ever. Just 38 percent of patient groups thought the pharmaceutical industry had an “excellent” or “good” reputation last

year, down from almost 45 percent in 2015, according to PatientView, a research firm that canvassed more than 1,400 patient groups from 105 countries. Not surprisingly, the pharmaceutical

industry fares poorest when it comes to pricing. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS IN-DEPTH